Lynne Lederman, PhD

Articles

Reducing Transfusion Burden in Patients With Beta-Thalassemia

December 11, 2019

A majority of adult patients with β-thalassemia who require regular red blood cell (RBC) transfusions experienced clinically meaningful and durable transfusion burden reduction associated with luspatercept (Reblozyl) in the phase III BELIEVE trial.